The work of a breast imager goes far beyond the pink-out of every October.
October and beyond, the role of breast imagers in radiology and healthcare overall extend far beyond the reading room. Breast imagers have a unique opportunity to closely interface with patients during screenings and follow-ups, offering not only encouragement but education.
For Dana N. Bonaminio, M.D., choosing breast imaging as a focus was easy. "Breast imaging is not one of those subspecialties where you sit in a dark room and read images all day. It's very patient-centric, radiology-centric and it puts you at the front, so we're not hiding behind a screen, we're really interacting with our patients."
Bonaminio, who is the Women's Imaging National Subspecialty Lead for Radiology Partners; Lead Breast Imager, Advanced Diagnostic Imaging; and Director of Breast Imaging at Ascension Saint Thomas Midtown Center for Breast Health in Nashville, Tennessee, uses her role to empower women to take control of their breast health.
She sat down with Diagnostic Imaging to discuss what motivates her, how her practice has changed post-pandemic, and what exciting trends she's hoping to take advantage of to improve her radiology practice.
BrightHeart Garners Third FDA Clearance for AI-Powered Assessments of Fetal Heart Ultrasound
May 14th 2025The latest FDA 510(k) clearance is for B-Right Views, an AI-enabled device, which provides automated detection of required views necessary for second- and third-trimester fetal heart ultrasound exams.
Mammography Study Compares False Positives Between AI and Radiologists in DBT Screening
May 8th 2025For DBT breast cancer screening, 47 percent of radiologist-only flagged false positives involved mass presentations whereas 40 percent of AI-only flagged false positive cases involved benign calcifications, according to research presented at the recent American Roentgen Ray Society (ARRS) conference.
Contrast-Enhanced Mammography Study Reveals 24 Percent Lower Sensitivity with Moderate/Marked BPE
April 30th 2025In comparison to minimal or mild background parenchymal enhancement on contrast-enhanced mammography (CEM), researchers found that moderate or marked BPE was associated with a 12 percent lower AUC for breast cancer detection.